Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles1 certified filing for “Executive Director Financial Planning & Analysis” (Financial Managers) in NJ: $317k–$317k, median $317k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles
- 1 certified filing for “Executive Director Financial Planning & Analysis” (Financial Managers) in NJ: $317k–$317k, median $317k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Build our future together:
The Executive Director, Global Lung Marketing, is a member of the Oncology Business Unit with accountability for leading and shaping commercialization and driving performance of Oncology solid tumor products under lung cancer indications globally, including full responsibility for US strategy and performance. In a complex competitive environment, this leader must critically assess how to continually drive growth in a mature brand and challenge the status quo worldwide as well as strong competency in launching.
The Executive Director, Global Lung Marketing, will set global tumor-level vision, leading the home-office and field marketing teams. Key responsibilities will include ensuring alignment with commercial imperatives and driving cross-functional integration across the US & International Teams. The Global Tumor Lead plays a critical role in bringing Regeneron science to lung cancer patients and delivering consistent commercial impact
When & where:
• In the Sleepy Hollow, NY office for 4 days a week
Discover your role:
• Leads, and inspires large marketing tumor focused marketing team with US and International HQ marketing team members as well as US field based team members. Establishes trust within the team at all levels, and with cross functional partners. Creates environment for learning agility, developing marketing talent and attracting leaders to the team.
• Establishes and evolves the global tumor strategy to drive differentiation and portfolio value across geographies, balancing US and International market input into global strategy build
• Plans business effectively for global and local market execution, being agile and able to balance/prioritize overall tactical initiatives to build and implement strategy
• Drives and leads global brand planning, able to use tumor critical thinking to develop meaningful brand and asset strategies to increase the value of the assets in these tumor areas.
• Works in close collaboration with Clinical, Medical Affairs and Field Medical to ensure strategic alignment with Medical Education strategic plans
• Provides strategic input into Lung Marketing Team collaboration with Insights and Data Analytics teams to conduct global market analyses and translate them into clear strategic choices and prioritization globally, ensuring team has insights and data needed to do so
• Represents the tumor area in decision-making forums (e.g., Commercial/Clinical cross-functional committees) to influence prioritization, resource allocation, and long-range planning based on scientific & commercial potential
• Works closely/collaboratively with other disease area leads to ensure overall alignment and harmony for the brand
• Manages team of direct reports and their respective teams, ensuring alignment with Global strategy and vision, and providing input/direction into critical activities/initiatives as well as prioritization
• Develops professional relationships and contacts with global physician experts and attends key congresses
• Creates processes and drives initiatives related to commercial launch and marketing efforts, proactively addressing hurdles in oncology asset commercialization where applicable
• Maintains line of sight to global P&L for skin cancer products across markets and accountable for US P&L
Operational
• Ensures the development, implementation, and administration of marketing processes, programs, and internal reports are consistent with corporate guidance and all regulatory, legal, ethical guidelines
• Supports team efforts to develop promotional content, including ensuring Medical/Legal/Regulatory Review committee effectiveness
• Manages and develops team members, ensuring their continued development and growth.
• Ensures that team develops
Apply on employer site ↗